BEIJING WANTAI BIOLOGICAL PHARMACY revenue breakdown overview

BEIJING WANTAI BIOLOGICAL PHARMACY revenue for the last year amounted to 5.51 B CNY, the most of which — 3.96 B CNY — came from its highest performing source at the moment, Vaccine, the year earlier bringing 8.49 B CNY. The greatest contribution to the revenue figure was made by China — last year it brought BEIJING WANTAI BIOLOGICAL PHARMACY 5.34 B CNY, and the year before that — 10.72 B CNY.